Atlas Trials

The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung

Clinical trial NCT03595891 · COMPLETED

Trial details

NCT number
NCT03595891
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Pulmonary Embolism (PE)Pulmonary Thromboembolism
Start date
2017-01-20
Primary completion
2021-01-29
Enrollment
660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.